3 Dividend Stocks To Consider With Yields Up To 5.7%
As global markets navigate a landscape of fluctuating interest rates and geopolitical uncertainties, investors are keenly observing the impact on stock indices worldwide. With U.S. corporate earnings ...
The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?
Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's ...
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...
These S&P 500 Stocks Yield 6%. They Could Be Better Than Bonds.
Investors are supposed to rely on bonds for stability and income. Fortunately, there are plenty of blue-chip stocks with yields that beat what investors can earn from broad-based bond funds. To sort ...
GSK outlines 2025 growth driven by specialty medicines and new product launches
Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...
American Association of Individual Investors23h
Which Is a Better Investment, Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. Stock?
Learn more about whether Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...
Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price ...
Investing1d
GSK Navigates Vaccine Setbacks With Strong Cash Flow and Expanding Pipeline
GSK (LON: GSK) has issued an update which inevitably reflects the difficulties faced in the last year, while also providing a host of reasons to be more upbeat on future prospects. Concerns over the ...
I’ve bought these dividend-paying blue-chips for lifelong passive income
Harvey Jones plans to spend his latter years living off the passive income from his FTSE 100 stocks. His latest buy is oil ...
6 Dividend Growth Stocks That Can Provide a Lifetime of Passive Income
Dividend stocks have long been a favorite for investors seeking reliable passive income. However, not all dividend-paying ...
American Association of Individual Investors7d
Which Is a Better Investment, Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. Stock?
Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.